Related Experiment Video
Updated: Aug 11, 2026

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
Published on: April 3, 2026
[Diagnosis and prognosis of atheroembolic disease]
A Rodríguez Jornet1, F J Andreu, R Orellana
1Servicios de Nefrología, Corporación Parc Taulí, Sabadell. arodriguez@cspt.es
Insights
Atheroembolic disease, often caused by invasive vascular procedures, frequently affects the kidneys. Early diagnosis via kidney biopsy is crucial, as the condition carries a poor prognosis with a high mortality rate.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Pathology
Context:
- Atheroembolic disease is an iatrogenic complication following vascular procedures or anticoagulant therapy.
- Cholesterol crystal embolism results from atherosclerotic plaque rupture, leading to arterial occlusion.
- The kidneys are common targets due to their high blood flow and renal artery proximity to the aorta.
Purpose:
- To describe the epidemiologic agents and clinical features of 19 atheroembolic disease cases.
- To highlight the diagnostic importance of kidney biopsy in atheroembolic disease.
- To report on the poor prognosis and high mortality associated with this condition.
Summary:
- Histologic examination of affected tissues diagnosed 19 cases of atheroembolic disease.
- Eosinophilia and renal failure were key clinical indicators, particularly in patients with ischemic nephropathy and atherosclerosis.
- 53% of cases followed invasive procedures, while 26% were spontaneous.
Impact:
- Kidney biopsy is vital for diagnosing atheroembolic disease, which has a 63% mortality rate within 18 months.
- The study identified multiple cholesterol emboli syndrome mimicking vasculitis, leading to multivisceral failure.
- Subacute presentation with progressive renal failure and hemodialysis indicates a poor prognosis; prevention and knowledge are key treatments.
Abstract:
Atheroembolic disease is recognized as an iatrogenic complication from an invasive vascular procedure, such as manipulation of the aorta during angiography or vascular surgery, and after anticoagulant and fibrinolytic therapy. Cholesterol crystal embolism is caused by showers of cholesterol crystals from an atherosclerotic aorta that occlude small arteries. The kidney is a frequent target organ for cholesterol emboli because of proximity of the renal arteries to abdominal aorta and it receive an enormous amount of blood flows. We describe the epidemiologic agents of 19 cases that were diagnosed by histologic sections of the affected tissues; the eosinophilia and the renal failure are the clinical features that guide to the diagnosis, in patients with ischemic nephropathy and general atherosclerosis. 53% among patients had a previous invasive procedure and 26% occurred spontaneously. We remark the importance of the kidney's biopsy in diagnosis of the atheroembolic disease and their bad prognosis with 63% of death rate in 18 months of average follow-up. We report patients with the multiple cholesterol emboli syndrome mimicking systemic vasculitis: they died by multivisceral acute failure. The subacute presentation of atheroembolic disease with progressive renal failure treated with hemodialysis is a sign of bad prognosis. The knowledge of the disease and their prevention are the better treatment.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis IV: Nursing Management
Atherosclerosis III: Management
